As of 10:30 AM on the 3rd, Komipharm is trading at 17,250 KRW, the same price as the previous day. This represents an 8.49% decrease compared to June 5. Komipharm is known as a manufacturer of veterinary vaccines and disinfectants.

Over the past five days, individual investors have net purchased 34,139 shares, while foreigners and institutions have net sold 64,879 shares and net purchased 25,726 shares, respectively.

On June 25, Komipharm became a market topic with the headline "Rise on COVID-19 Treatment Clinical Trial Application."

※Source: AI Investment Assistant AI Rasero

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing